Procter & Gamble Health Limited (NSE:PGHL)

Procter & Gamble Health Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Operating Revenue	12,844	12,181	11,513	12,296	11,144	10,087
Revenue	12,844	12,181	11,513	12,296	11,144	10,087
Revenue Growth (YoY)	10.75%	5.80%	-6.37%	10.34%	10.48%	13.52%
Cost of Revenue	3,441	3,490	3,425	3,834	3,531	3,245
Gross Profit	9,403	8,691	8,087	8,463	7,614	6,842
Selling, General & Admin	2,483	2,333	2,682	2,811	2,776	2,421
Other Operating Expenses	2,767	2,689	2,340	2,412	2,141	1,943
Operating Expenses	5,475	5,260	5,296	5,504	5,188	4,669
Operating Income	3,928	3,431	2,791	2,959	2,426	2,173
Interest Expense	-5.2	-6.3	-7.2	-7.7	-4.2	-8
Interest & Investment Income	70.4	70.4	117.3	143.3	110.7	150.6
Currency Exchange Gain (Loss)	-1.6	-1.6	2.7	3.4	-6.9	-8.9
Other Non Operating Income (Expenses)	90.1	54.4	36.3	30.1	21.2	30.4
EBT Excluding Unusual Items	4,082	3,548	2,940	3,128	2,546	2,337
Merger & Restructuring Charges	201.9	-	-201.9	-	-	-
Gain (Loss) on Sale of Assets	-1.3	-1.3	-5.1	7.1	-5.4	-4.2
Asset Writedown	-	-	-	7.3	-7.3	-
Other Unusual Items	-201.9	-201.9	-	-	-	-
Pretax Income	4,081	3,345	2,733	3,142	2,534	2,333
Income Tax Expense	1,013	832.6	723.4	847.3	608.5	564.8
Earnings From Continuing Operations	3,068	2,512	2,010	2,295	1,925	1,768
Net Income	3,068	2,512	2,010	2,295	1,925	1,768
Net Income to Common	3,068	2,512	2,010	2,295	1,925	1,768
Net Income Growth	40.90%	24.98%	-12.42%	19.19%	8.89%	6.56%
Shares Outstanding (Basic)	17	17	17	17	17	17
Shares Outstanding (Diluted)	17	17	17	17	17	17
Shares Change (YoY)	-0.01%	-0.00%	-	-	-	-0.08%
EPS (Basic)	184.83	151.33	121.08	138.24	115.98	106.51
EPS (Diluted)	184.61	151.11	121.00	138.00	115.98	106.51
EPS Growth	40.74%	24.89%	-12.32%	18.99%	8.89%	6.72%
Free Cash Flow	-	2,135	2,066	1,935	1,316	1,947
Free Cash Flow Per Share	-	128.63	124.44	116.58	79.28	117.28
Dividend Per Share	-	166.667	110.000	95.000	52.500	40.000
Dividend Growth	-	51.52%	15.79%	80.95%	31.25%	42.86%
Gross Margin	73.21%	71.35%	70.25%	68.82%	68.32%	67.83%
Operating Margin	30.58%	28.17%	24.24%	24.06%	21.77%	21.54%
Profit Margin	23.89%	20.62%	17.46%	18.66%	17.28%	17.53%
Free Cash Flow Margin	-	17.53%	17.94%	15.74%	11.81%	19.30%
EBITDA	4,104	3,621	3,034	3,188	2,648	2,424
EBITDA Margin	31.95%	29.73%	26.36%	25.92%	23.76%	24.03%
D&A For EBITDA	176.03	190.13	243	229	222.1	251.1
EBIT	3,928	3,431	2,791	2,959	2,426	2,173
EBIT Margin	30.58%	28.17%	24.24%	24.06%	21.77%	21.54%
Effective Tax Rate	24.81%	24.89%	26.47%	26.97%	24.02%	24.21%
Revenue as Reported	13,005	12,305	11,669	2,480	11,276	10,268
Advertising Expenses	-	-	526.5	744.9	1,095	874.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.